Alan Cooper
he/him/his
About
Research
Publications
2024
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition.
Cooper A, Tumuluru S, Kissick K, Venkataraman G, Song JY, Lytle A, Duns G, Yu J, Kotlov N, Bagaev A, Hodkinson B, Srinivasan S, Smith SM, Scott DW, Steidl C, Godfrey JK, Kline J. CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition. J Clin Oncol 2024, 42: 467-480. PMID: 38079587, DOI: 10.1200/JCO.23.01574.Peer-Reviewed Original Research
2023
TIGIT is a key inhibitory checkpoint receptor in lymphoma.
Godfrey J, Chen X, Sunseri N, Cooper A, Yu J, Varlamova A, Zarubin D, Popov Y, Jacobson C, Postovalova E, Xiang Z, Nomie K, Bagaev A, Venkataraman G, Zha Y, Tumuluru S, Smith SM, Kline JP. TIGIT is a key inhibitory checkpoint receptor in lymphoma. J Immunother Cancer 2023, 11 PMID: 37364933, DOI: 10.1136/jitc-2022-006582.Peer-Reviewed Original Research
Links
Get In Touch
Contacts
Email